Free Trial

Ascent Group LLC Acquires New Holdings in Mettler-Toledo International, Inc. $MTD

Mettler-Toledo International logo with Medical background

Key Points

  • Ascent Group LLC has invested approximately $344,000 in Mettler-Toledo International, acquiring 291 shares, according to a recent SEC filing.
  • Institutional ownership in Mettler-Toledo International is notably high at 95.07%, with several firms, including Vanguard Group and GAMMA Investing, increasing their holdings during the first quarter.
  • Mettler-Toledo's stock is currently trading at $1,280.28 and has a market capitalization of $26.37 billion, with the firm expecting to post an EPS of 42.71 for the current fiscal year.
  • MarketBeat previews the top five stocks to own by November 1st.

Ascent Group LLC bought a new stake in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) in the 1st quarter, according to its most recent disclosure with the SEC. The fund bought 291 shares of the medical instruments supplier's stock, valued at approximately $344,000.

Other hedge funds have also made changes to their positions in the company. Greenleaf Trust grew its holdings in shares of Mettler-Toledo International by 1.2% in the first quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier's stock valued at $1,030,000 after purchasing an additional 10 shares in the last quarter. Brooklyn Investment Group grew its stake in shares of Mettler-Toledo International by 12.8% in the first quarter. Brooklyn Investment Group now owns 88 shares of the medical instruments supplier's stock worth $104,000 after acquiring an additional 10 shares in the last quarter. Sequoia Financial Advisors LLC increased its position in shares of Mettler-Toledo International by 1.8% during the first quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier's stock worth $740,000 after acquiring an additional 11 shares during the period. Albion Financial Group UT raised its stake in shares of Mettler-Toledo International by 1.5% in the first quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier's stock valued at $890,000 after acquiring an additional 11 shares in the last quarter. Finally, TD Private Client Wealth LLC boosted its holdings in Mettler-Toledo International by 5.4% in the first quarter. TD Private Client Wealth LLC now owns 214 shares of the medical instruments supplier's stock valued at $253,000 after purchasing an additional 11 shares during the period. Institutional investors and hedge funds own 95.07% of the company's stock.

Analyst Ratings Changes

A number of research firms have issued reports on MTD. Robert W. Baird increased their price target on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a research report on Monday, August 4th. Barclays assumed coverage on shares of Mettler-Toledo International in a report on Tuesday, June 24th. They set an "overweight" rating and a $1,325.00 price target for the company. Citigroup raised their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a report on Thursday, August 21st. UBS Group raised Mettler-Toledo International from a "neutral" rating to a "buy" rating and dropped their target price for the company from $1,530.00 to $1,350.00 in a report on Tuesday, May 20th. Finally, Evercore ISI decreased their price target on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating for the company in a report on Monday, August 4th. Five research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, Mettler-Toledo International has a consensus rating of "Moderate Buy" and a consensus target price of $1,311.11.

Check Out Our Latest Stock Analysis on MTD

Mettler-Toledo International Stock Performance

Shares of MTD stock traded up $6.43 during mid-day trading on Wednesday, hitting $1,282.53. 27,275 shares of the stock were exchanged, compared to its average volume of 168,171. The stock's fifty day simple moving average is $1,261.83 and its two-hundred day simple moving average is $1,185.40. Mettler-Toledo International, Inc. has a 12-month low of $946.69 and a 12-month high of $1,521.01. The stock has a market capitalization of $26.42 billion, a price-to-earnings ratio of 32.49, a P/E/G ratio of 3.78 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The firm had revenue of $983.22 million during the quarter, compared to analysts' expectations of $957.41 million. During the same period in the prior year, the firm earned $9.65 EPS. The business's revenue was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, research analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Thomas P. Salice sold 1,062 shares of the stock in a transaction on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the sale, the director directly owned 283 shares of the company's stock, valued at $368,154.70. This trade represents a 78.96% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Gerry Keller sold 165 shares of the business's stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the transaction, the insider owned 94 shares in the company, valued at $123,012.16. The trade was a 63.71% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,827 shares of company stock valued at $2,371,208 in the last ninety days. 0.77% of the stock is currently owned by company insiders.

About Mettler-Toledo International

(Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Read More

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Should You Invest $1,000 in Mettler-Toledo International Right Now?

Before you consider Mettler-Toledo International, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.

While Mettler-Toledo International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.